📰 Melissab Epperly News
Page 2 - Melissab Epperly News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Melissab Epperly. Real-time updates on events, politics, business and more.
November 12, 2023
Wedbush lowered shares of Zentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) from an outperform rating to a neutral rating in a research note released on Wednesday, MarketBeat reports. They currently have $12.00 price objective on the stock, down from their previous price objective of $38.00. Wedbush also issued estimates for Zentalis Pharmaceuticals’ Q4 2023 earnings at […]
November 11, 2023
Zentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) had its target price reduced by HC Wainwright from $55.00 to $46.00 in a report published on Tuesday, Benzinga reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for Zentalis Pharmaceuticals’ Q4 2023 earnings at ($0.83) EPS, FY2023 earnings at ($4.44) EPS, […]
October 25, 2023
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) shares dropped 4.1% on Monday . The company traded as low as $17.22 and last traded at $17.22. Approximately 162,213 shares traded hands during mid-day trading, a decline of 77% from the average daily volume of 709,252 shares. The stock had previously closed at $17.95. Analysts Set […]
October 18, 2023
Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) traded down 3.2% on Monday . The stock traded as low as $18.21 and last traded at $18.34. 146,579 shares were traded during trading, a decline of 79% from the average session volume of 706,325 shares. The stock had previously closed at $18.94. Wall Street […]
May 4, 2023
Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating) have been given an average rating of “Buy” by the eleven research firms that are currently covering the stock, MarketBeat Ratings reports. Eight research analysts have rated the stock with a buy recommendation. The average 1-year target price among brokerages that have updated their coverage on […]
April 11, 2023
Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating) have received an average rating of “Buy” from the eleven brokerages that are currently covering the firm, MarketBeat.com reports. Eight investment analysts have rated the stock with a buy rating. The average 1-year target price among brokers that have issued ratings on the stock in the […]
April 7, 2023
Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating) rose 3.6% on Wednesday . The company traded as high as $18.28 and last traded at $18.12. Approximately 284,046 shares changed hands during trading, a decline of 49% from the average daily volume of 559,839 shares. The stock had previously closed at $17.49. Wall Street Analysts […]
April 5, 2023
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating) rose 3.6% during trading on Wednesday . The stock traded as high as $18.28 and last traded at $18.12. Approximately 284,046 shares traded hands during trading, a decline of 49% from the average daily volume of 559,839 shares. The stock had previously closed at $17.49. Wall Street Analyst […]
March 30, 2023
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating) shares were down 5.7% on Thursday . The stock traded as low as $16.42 and last traded at $16.59. Approximately 145,102 shares changed hands during mid-day trading, a decline of 74% from the average daily volume of 564,899 shares. The stock had previously closed at $17.60. Wall Street […]
March 24, 2023
Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating) saw an uptick in trading volume on Friday . 266,580 shares traded hands during trading, a decline of 51% from the previous session’s volume of 541,191 shares.The stock last traded at $17.66 and had previously closed at $17.83. Wall Street Analyst Weigh In A number of […]